DAY 1 | JULY 12 | BOSTON | 8:30AM - 6:30PM
7:30AM - REGISTRATION OPENS
8:30AM - FUTURE DIRECTIONS IN WOUND CARE AND OPPORTUNITIES FOR INNOVATION
- - Discouraging further entry of ‘me-too’ products and identifying true unmet needs
- - Advice for nascent wound care companies when it comes to effective ideation, concept management, and identifying strategic partnerships
- - Adapting to changing market dynamics such as nurse shortages and an increased acceptance of digital health solutions
Kris Kieswetter
Global Senior Director, Applied Medical Sciences
3M
9:00AM - PANEL: DRIVING COMMERCIALLY VIABLE WOUND CARE INNOVATION AND BUILDING EFFECTIVE PARTNERSHIPS
- - A look to the future of wound care innovation, and advice for emerging companies looking to bring their treatments to market
- - How can industry work collaboratively to help drive innovation in wound care, remove shared challenges for innovative product development, and truly improve patient outcomes?
PANELISTS:
Kris Kieswetter
Global Senior Director, Applied Medical Sciences
3M
Ibraheem Badejo
Senior R&D Director, External, Front End Innovation
Johnson & Johnson
09:30AM - NETWORKING BREAK
09:45AM - PRE-SCHEDULED 1-2-1 MEETINGS
Pre-organize 15-minute, 1-2-1 private meetings with any of our attendees, partners, or speakers via our online platform.
The platform will open 2 weeks prior to the conference
ADVANCING HEALTH EQUITY, R&D COLLABORATIONS, AND REGULATORY ON INITIATIVES
10:15AM - ADDRESSING DISPARITIES IN WOUND CARE WITH EVIDENCE-BASED THERAPEUTICS
- - Recent evidence-based wound care therapeutics offer hope for addressing such health inequities
- - What specific impact can more durable wound healing have on patient and payer centric outcomes?
Mike Griffiths
Chief Executive Officer
Advanced Oxygen Therapy
10:45AM - ENHANCING WOUND CARE R&D COLLABORATIONS
- - Uniting projects across the wound care R&D value chain
Jason Smith
Director of R&D
Integra
Tim Ganey
Chief Scientific Officer
VIVEX Biologics
11:30AM - DRIVING WOUND CARE INNOVATION FROM A REGULATORY PERSPECTIVE
- - Understanding the FDA's perspective on wound care innovation and the current lack of innovative wound care products
- - How is the FDA looking to work with people within the wound care community?
Julie Morabito
Assistant Director, Division of Plastic and Reconstructive Surgery, Center for Devices and Radiological Health
FDA
12:00PM - 1:00PM - LUNCH BREAK
1:00PM - PANEL: CURRENT PERSPECTIVES ON WOUND CARE BIOLOGICS
- - An analysis of recent trends and increased demand for wound care biologics
MODERATOR:
Jignesh Patel
Head of Biologics and Chief Scientific Officer
Smith & Nephew
PANELISTS:
Nikolai Sopko
Regenerative Medicine
PolarityTE
REST OF PANELISTS TBA
1:45PM - ASSESSING HEALING OUTCOMES OF CONTINUOUS TOPICAL OXYGEN THERAPY (CTOT) WITH NEAR INFRARED SPECTROSCOPY (NIRS)
- - Review the growing body of evidence supporting the use of topical oxygen therapy as an adjunct treatment for chronic wounds
- - Explore cTOT's effect on overall patient outcomes including healing, pain, and durability
- - Share real-life case studies that used NIRS to measure the increase of oxygenated hemoglobin on wounds receiving cTOT
Windy Cole
Global Medical Affairs Director
Natrox® Wound Care
ENABLING A PREVENTION-FOCUSED APPROACH
2:15PM - PANEL: WOUND PREVENTION AND PREHABILITATION
- - Determining the benefits of pred-admission interventions (prehabilitation)
- - Enhancing the ability of wound care patients' capacity to withstand a forthcoming stessor
- - Driving new regulations that power preventive measures, such as facilitating additional research on amputation prevention, quality services performed by a podiatrist, and increased screening for issues such as peripheral artery disease
MODERATOR:
David Alper
Board Advisor, American Diabetes Association
Prevention Alliance
REST OF PANELISTS TBA
2:45PM - NETWORKING BREAK
3:00PM - PRE-SCHEDULED 1-2-1 MEETINGS
Pre-organize 15-minute, 1-2-1 private meetings with any of our attendees, partners, or speakers via our online platform. The platform will open 2 weeks prior to the conference
INNOVATIONS IN WOUND DIAGNOSTICS
3:15PM - PANEL: NOVEL BIOMARKERS AND NEXT GENERATION DIAGNOSTIC INNOVATIONS
- - Unpacking recent developments in ‘advanced' wound diagnostics - namely biomarkers and imaging systems
- - Identifying biomarkers and imaging systems with the greatest evidence to support their potential clinical utility
- - Transforming wound care into a precision medicine by combining diagnostic innovation with advances in telemedicine, synthetic biology, and smart wearables
MODERATOR:
Ira Herman
Senior Director, Biological Sciences
Precision Healing
PANELISTS:
Tom Serena
Founder & CEO
SerenaGroup
Mitch Sanders
Chief Executive Officer
ProDevLabs
4:00PM - EFFECTIVELY GENERATING EVIDENCE FOR WOUND DIAGNOSTIC DEVICES
- - Uncovering strategic approaches taken to introduce and validate the benefits of a novel diagnostic imaging technology to the wound care field
- - This will include lessons learned, successes, and evidence initiatives undertaken to educate the field on how disruptive technology benefits clinicians, facilities, health systems, and wound care patients
Monique Rennie
VP of Medical Affairs & Reimbursement
Moleculight
4:30PM - 5:30PM - ROUNDTABLE DISCUSSIONS
A) THE IMPORTANCE OF MEDICAL EDUCATION TO SUPPORT YOUR STRATEGIC GOALS
A discussion around various types of medical education projects (consensus documents, case-studies, etc.) that can be carried out to aid product/service adoption, demonstrate its use in clinical practice, and support appropriate conduct. Examples of what has worked well for companies in the past.
MODERATOR:
Anthony Kerr
Managing Director
Journal of Wound Care
B) COLD PLASMA THERAPY - DEVELOPING A BREAKTHROUGH THERAPY IN A HIGHLY COMPETITIVE MARKET
When developing first-in-class/breakthrough wound care therapies (such as cold plasma therapy), how do we deal with the associated challenges, including: raising capital, forming new coverage policies and navigating reimbursement landscapes, designing and conducting novel trials, integrating new therapy into traditional clinical workflows, and more. Highlighting the difficulties of entering foreign markets (various regulatory and reimbursement considerations) and operating in an industry that is dominated by a small number of large corporations.
MODERATOR:
Jens Kirsch
Chief Executive Officer
Terraplasma Medical
C) GROWTH AS A WOUND CARE STARTUP - WHAT CAN WE LEARN FROM PAST AND EMERGING TRENDS?
An overview of market trends for wound care startups and a discussion around what has changed over the past year. Where are their specific opportunities for emerging companies?
MODERATOR:
Susan Paquette
Vice President & General Manager, Wound
SmartTRAK
D) WOUND CARE 2.0 - CREATING A WOUND CARE CULTURE IN LONG-TERM CARE
A culture is an environment of shared values and beliefs. By changing the wound care paradigm from the tactical cause and effect of wound care itself, to making it a core institutional priority for improving patient care and quality of life, we can transform wound care into a dynamic component of organizational character and brand. This roundtable will discuss steps towards creating a vibrant wound care culture within one's organization.
MODERATOR:
Arnie Andersen
Vice President of Post Acute Care
Gentell, Inc.
E) CORRECTING HEALTH INEQUITIES, REDUCING HOSPITALIZATIONS AND AMPUTATIONS, AND SUSTAINABLY HEALING CHRONIC WOUNDS THROUGH TOPICAL WOUND OXYGEN HOMECARE THERAPY
MODERATOR:
Mike Griffiths
Chief Executive Officer & Medical Director
Advanced Oxygen Therapy Inc.
5:30PM - NETWORKING DRINKS - SPONSORED BY ALIRA HEALTH
6:30PM - END OF DAY 1
DAY 2 | JULY 13 | BOSTON | 9:00AM - 4:00PM
8:30AM - CEO & FOUNDERS FORUM
The perfect environment for you to establish a credible, peer-to-peer network of wound care entrepreneurs. As the name suggests, this is an exclusive meeting space available to CEOs and Founders only. Join this forum to form relationships with other with like-minded peers and explore the plethora of partnership opportunities available to wound care decision makers.
9:00AM - INNOVATION SHOWCASE
This session provides the unique opportunity to listen to, and engage with, some of the most innovative wound care companies globally. Focusing on early stage and later-stage funding, 9 wound care startups and SMEs picked by our esteemed selection committee will take to the stage in front of 100+ potential partners. Through a series of rapid-fire presentations, these pioneers will demonstrate their vision of the future of wound care, and how their product, technology, or service fits into it.
SELECTION COMMITTEE:
Kris Kieswetter
Global Senior Director, Applied Medical Sciences
3M
Parth Desai
Principal
Flare Capital Partners
Thomas Busby
Senior Vice President
Outcome Capital
Ibraheem Badejo
Senior R&D Director, External Front End Innovation
Johnson & Johnson
Artem Trosyuk
Principal
R42 Group
In partnership with the Journal of Wound Care
10:10AM INSIGHTS AND TRENDS IN ADVANCED WOUND CARE
- - An analysis of the current state of the wound care market
- - How big is the market currently and at what rate is it growing?
Susan Paquette
Vice President & General Manager, Wound
SmartTRAK
10:30AM - NETWORKING BREAK
11:00AM - PRE-SCHEDULED 1-2-1 MEETINGS
Pre-organize 15-minute, 1-2-1 private meetings with any of our attendees, partners, or speakers via our online platform. The platform will open 2 weeks prior to the conference.
VALUE-BASED CARE
11:30AM - TRANSITIONING TO VALUE-DRIVEN CARE WOUND CARE
- - Combining policy levers, reimbursement strategies, technical innovation, and boots-on-the-ground care to move closer to value-driven care
Jon Bloom
Chief Executive Officer
Podimetrics
12:00PM - INNOVATIVE MODELS OF VALUE-BASED WOUND CARE
- - Explore the concept of value-based wound care
- - Describe Corstrata's current role in advancing value-based wound care
- - Discuss the opportunities and challenges of implementing new models of value-based wound care delivery - value-based payment models, accountable care organizations, etc.
Katherine Piette
Chief Executive Officer
Corstrata
12:30PM - PANEL DISCUSSION: DRIVING THE ADOPTION OF NEW MODELS OF CARE
- - Identifying key factors that will help to drive systems to adopt new models of care
MODERATOR:
Parth Desai
Principal
Flare Capital Partners
PANELISTS:
Jon Bloom
Chief Executive Officer
Podimetrics
Katerine Piette
Chief Executive Officer
Corstrata
Mellisa Bailey
VP of Sales & Marketing
Swift Medical
Javier Guirola
Director of Medical Affairs
PolyNovo
1:00PM - 2:00PM LUNCH BREAK
NEW FRONTIERS IN PATIENT ENGAGEMENT, ADHERENCE, AND TRIAL DESIGN
2:00PM - WOUND CARE AND REMOTE PATIENT MONITORING: THE NEW FRONTIER
- - Patients' engagement and adherence is crucial to improve outcomes.
- - Both secondary prevention and acute care of Diabetic Foot Ulcers (DFU), Venous Leg Ulcers (VLUs) and pressure wounds (Decubitus Ulcers) may benefit from new IoT cloud connected devices that quantify and improve patient clinician interaction.
- - Real life examples, new independent research studies and enabling technologies will be presented.
Davide Vigano
Co-founder & Chief Executive Officer
Sensoria Health
2:30PM - PANEL DISCUSSION: STRATEGIES FOR EFFECTIVE CLINICAL TRIAL DESIGN
- - Overcoming challenges in clinical trial execution and difficulties with patient enrolment
- - Accounting for varying standard of care protocols and study populations when designing trials
- - Identifying clinical meaningful endpoints
CO MODERATORS:
Chris Rao
Senior Vice President, Clinical Operations
Alira Health
Kenny Carberry
Vice President of Business Development
Alira Health
Dan King
Director of Marketing
PolyNovo
3:00PM - COFFEE BREAK
3:30PM - SHAPING THE FUTURE OF WOUND CARE
Highlighting innovative, early-stage work that has great potential to advance standards of care and improve patient outcomes
MODERATOR:
Mitch Sanders
Chief Scientific Officer
Alira Health